arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

MetaVia Inc.

MTVA
$1.62 ▼ -0.05 (-2.99%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
47 Visible periods
20 Metrics
Peer-ranked Benchmarks
Price Chart
22
Health
Poor
Bearish
auto_awesome

Analytical Summary

MetaVia Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $9.6M
Dividend Yield
Revenue Growth
Op. Margin
ROIC -78.9%
FCF / Share $-0.63
Trailing P/E
Price / Book 1.6x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

47-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-3.82M
↓ -4.1%
FCF / Share Free cash flow per share
$-0.63
↑ +27.6%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
1
Cash Quality
73

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 13 years · 47 quarters